The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC lessened its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 4.2% in the 4th quarter, Holdings Channel reports. The firm owned 4,092 shares of the medical device company’s stock after selling 180 shares during the period. Sequoia Financial Advisors LLC’s holdings in Cooper Companies were worth $376,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. CIBC Asset Management Inc raised its holdings in shares of Cooper Companies by 8.4% in the 3rd quarter. CIBC Asset Management Inc now owns 28,993 shares of the medical device company’s stock valued at $3,199,000 after buying an additional 2,245 shares during the period. Empowered Funds LLC grew its position in Cooper Companies by 8.7% in the 3rd quarter. Empowered Funds LLC now owns 3,086 shares of the medical device company’s stock valued at $341,000 after acquiring an additional 248 shares in the last quarter. Thrivent Financial for Lutherans increased its stake in Cooper Companies by 26.9% during the third quarter. Thrivent Financial for Lutherans now owns 72,001 shares of the medical device company’s stock worth $7,945,000 after purchasing an additional 15,258 shares during the period. Swiss National Bank boosted its stake in shares of Cooper Companies by 0.4% in the third quarter. Swiss National Bank now owns 590,900 shares of the medical device company’s stock valued at $65,200,000 after purchasing an additional 2,400 shares during the period. Finally, LMR Partners LLP grew its holdings in shares of Cooper Companies by 23.3% in the third quarter. LMR Partners LLP now owns 54,744 shares of the medical device company’s stock valued at $6,040,000 after purchasing an additional 10,330 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on COO. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Friday, March 7th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Morgan Stanley lowered their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Citigroup reduced their price target on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $111.89.

Cooper Companies Price Performance

COO stock opened at $80.04 on Wednesday. The business has a 50 day moving average price of $90.68 and a 200 day moving average price of $98.56. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock has a market cap of $16.01 billion, a price-to-earnings ratio of 41.05, a PEG ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a fifty-two week low of $77.05 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.